Breakthrough Prizes 2026: $18.75M for Gene Therapies, ALS Gene and Muon g-2 at 127 ppb Precision

The Breakthrough Prize Foundation awarded six $3 million prizes on April 18 in Los Angeles for gene therapies targeting inherited blindness, sickle cell disease, and beta-thalassemia, plus the C9orf72 gene discovery linking ALS and frontotemporal dementia. Muon g-2 measurements reached 127 parts per billion precision, 30,000 times better than the 1965 benchmark, hinting at physics beyond the Standard Model. Totaling $18.75 million this year and over $340 million in 15 years, these honors drive biotech and physics markets into 2026.